Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2014
10/09/2014US20140303127 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
10/09/2014US20140303121 Heterocyclic compounds and uses thereof
10/09/2014US20140302069 Modulators of c3a receptors
10/09/2014US20140302010 Substituted benzimidazoles
10/09/2014US20140301978 Methods for using 1,2,4-oxadiazole benzoic acid compounds
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/08/2014EP2786994A1 Compositions and methods for controlling nematodes
10/08/2014EP2786993A1 Compositions and methods for controlling nematodes
10/08/2014EP2786992A1 Compositions and methods for controlling nematodes
10/08/2014EP2785729A1 Oligonucleotides for treating expanded repeat diseases
10/08/2014EP2785713A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
10/08/2014EP2785711A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785709A1 Aminopyrimidine derivatives as lrrk2 modulators
10/08/2014EP2785708A1 Insecticidal triazinone derivatives
10/08/2014EP2785707A1 Novel 2h-indazoles as ep2 receptor antagonists
10/08/2014EP2785699A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785695A1 New bicyclic dihydroisoquinoline-1-one derivatives
10/08/2014EP2785693A1 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors
10/08/2014EP2785692A1 Substituted anilines as ccr(4) antagonists
10/07/2014US8853420 Compounds
10/07/2014US8853412 Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
10/07/2014US8853410 Process for preparing substituted isoxazoline compounds and their precursors
10/07/2014US8853408 Cyclopropylamines as LSD1 inhibitors
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853392 Benzamide mGluR5 positive allosteric modulators and methods of making and using same
10/07/2014US8853391 Tricyclic azaindoles
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853243 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
10/07/2014US8853217 Compounds useful as inhibitors of ATR kinase
10/07/2014US8853210 Methods and intermediates for preparing pharmaceutical agents
10/07/2014US8853206 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
10/07/2014US8853199 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
10/07/2014US8852634 Dosage formulation
10/02/2014WO2014160873A1 Benzimidazolone derivatives as bromodomain inhibitors
10/02/2014WO2014160810A1 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
10/02/2014WO2014160668A1 Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors
10/02/2014WO2014160649A1 Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
10/02/2014WO2014160586A1 Cyclic n-acyl o-amino phenol cbi derivative
10/02/2014WO2014160521A1 Piperazine derivatives and their use as kit modulators
10/02/2014WO2014160401A1 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
10/02/2014WO2014159690A1 Dna-pk inhibitors
10/02/2014WO2014159657A1 Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
10/02/2014WO2014159637A1 Methods of treating b2-bradykinin receptor mediated angioedema
10/02/2014WO2014157994A1 Novel oxazolidinone derivative as cetp inhibitor, its preparation method, and pharmaceutical composition comprising the same
10/02/2014WO2014157494A1 Material for organic electroluminescent elements, organic electroluminescent element, display device and lighting device
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014154925A1 Neurogenic compounds comprising melatonin and the efficacy thereof in in vivo experiments for use in the treatment of diseases of the nervous system
10/02/2014WO2014154829A1 Herbicidal compounds
10/02/2014WO2014154794A1 Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
10/02/2014WO2014154762A1 Dihydroquinazolinone analogues as brd4 inhibitors
10/02/2014WO2014154760A1 Indolinone analogues as brd4 inhibitors
10/02/2014WO2014154727A1 Biaryl-propionic acid derivatives and their use as pharmaceuticals
10/02/2014WO2014154726A1 Biaryl-propionic acid derivatives and their use as pharmaceuticals
10/02/2014WO2014154682A1 Novel viral replication inhibitors
10/02/2014WO2014154612A1 Novel pyridine derivatives
10/02/2014WO2014154530A1 Microbiocidal pyrazole derivatives
10/02/2014US20140296531 Novel semi-synthetic small molecules for the treatment parasitic disease
10/02/2014US20140296514 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
10/02/2014US20140296311 Gamma secretase modulators
10/02/2014US20140296296 Biaryl-Propionic Acid Derivatives and their Use as Pharmaceuticals
10/02/2014US20140296295 2-alkoxy-substituted dicyanopyridines and their use
10/02/2014US20140296252 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
10/02/2014US20140296246 Benzimidazolone derivatives as bromodomain inhibitors
10/02/2014US20140296239 Biaryl-propionic acid derivatives and their use as pharmaceuticals
10/02/2014US20140296238 Dihydropyrazoles
10/02/2014US20140296237 Picolinamide derivatives as ttx-s blockers
10/02/2014US20140296236 Quinolines as fgfr kinase modulators
10/02/2014US20140296230 Dihydroquinazolinone analogues
10/02/2014US20140296229 Indolinone analogues
10/02/2014US20140296228 Inhibitors of human immunodeficiency virus replication
10/02/2014US20140296225 Inhibitors of the Renal Outer Medullary Potassium Channel
10/02/2014US20140296214 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
10/02/2014US20140296206 Compositions useful for treating disorders related to kit
10/02/2014US20140296202 Substituted piperidinyl compounds useful as gpr119 agonists
10/02/2014US20140296200 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
10/02/2014US20140296196 Nk1 antagonists
10/01/2014EP2782913A2 Isoxazole treatments for diabetes
10/01/2014EP2782903A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
09/2014
09/30/2014US8846948 Compounds
09/30/2014US8846947 Benzimidazoles and related analogs as sirtuin modulators
09/30/2014US8846943 Pyrrole derivative and process for production thereof
09/30/2014US8846936 Sulfonyl compounds which modulate the CB2 receptor
09/30/2014US8846934 Substituted oxazolidinones and their use
09/30/2014US8846933 N-link hydroxamic acid derivatives useful as antibacterial agents
09/30/2014US8846930 Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
09/30/2014US8846928 Benzamides and nicotinamides as Syk modulators
09/30/2014US8846924 Sulfonamide derivatives of polycyclic dyes used for analytical applications
09/30/2014US8846918 Compounds useful as inhibitors of ATR kinase
09/30/2014US8846910 Matrix metalloproteinase inhibitors
09/30/2014US8846909 Bicyclic heteroaryl kinase inhibitors and methods of use
09/30/2014US8846908 Tricyclic carbamate JAK inhibitors
09/30/2014US8846746 Pyrazole compound and pharmaceutical use thereof
09/30/2014US8846738 Fungicide active substance combinations
09/30/2014US8846733 Oxazolyl-methylether derivatives as ALX receptor agonists
09/30/2014US8846729 2-thio-1,3,4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
09/30/2014US8846727 Haloalkyl heteroaryl benzamide compounds
09/30/2014US8846726 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
09/30/2014US8846719 Isoxazolo-pyridine derivatives
09/30/2014US8846705 Diaminopyrimidines as P2X3 and P2X2/3 antagonists
09/30/2014US8846687 Pyrazine compounds as PI3 kinase inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 647